Comparison of perioperative outcomes and cost of robotic-assisted laparoscopy, laparoscopy and laparotomy for endometrial cancer

Author(s):  
Pluvio J. Coronado ◽  
Miguel A. Herraiz ◽  
Javier F. Magrina ◽  
María Fasero ◽  
Jose A. Vidart
2021 ◽  
Author(s):  
Katrin Roth ◽  
Klaus Kaier ◽  
Peter Stachon ◽  
Constantin von zur Mühlen ◽  
Florin-Andrei Taran ◽  
...  

Abstract Purpose The present study compared the use and outcomes of open surgical staging, laparoscopic surgical staging and robotic-assisted surgical staging in all patients suffering from endometrial carcinoma undergoing surgery in Germany between 2007 and 2018. Methods All patients with the diagnosis of endometrial carcinoma undergoing open surgical staging, laparoscopic surgical staging and robotic-assisted surgical staging were identified by international classification of diseases (ICD) or specific operational codes (OPS) within the database of the German federal bureau of statistics. Results Between 2007 and 2018, a total of 85,204 patients underwent surgery for endometrial carcinoma. Since 2013 laparoscopy was the leading approach in the surgical staging. The use of robotic-assisted laparoscopy increased steadily since 2011 with a share of 3% in 2018. Open surgical staging was associated with a higher risk of in-hospital mortality than laparoscopic surgical staging (1.3% vs. 0.2%, p < 0.001), of prolonged mechanical ventilation (1.3% vs. 0.2%, p < 0.001), and of prolonged hospital stay (13.7 ± 10.2 vs. 7.2 ± 5.3, p < 0.001). 0.04% patients undergoing laparoscopy were converted to laparotomy. The perioperative outcomes of surgical staging by laparotomy compared with robotic-assisted were comparable. None of the robotic-assisted treated patients died or was converted into laparotomy. Costs were highest in the open laparotomy staging group, followed by robotic assisted. Conventional laparoscopic approach caused lowest costs (8286 ± 7533€ vs. 7083 ± 3893€ vs. 6047 ± 3509€). Conclusion The present analysis shows that conventional laparoscopy is the standard therapy of endometrial carcinoma with excellent in-hospital outcomes in clinical practice. Robotic-assisted laparoscopy is an emerging technology with convincing results similar to


2016 ◽  
Vol 01 (01) ◽  
Author(s):  
Farr Nezhat M D ◽  
Radu Apostol D O ◽  
Mario Vega M D ◽  
Ido Sirota M D ◽  
Patrick Vetere M D

2019 ◽  
Vol 35 (6) ◽  
pp. 350-355
Author(s):  
Farr Nezhat ◽  
Radu Apostol ◽  
Mario Vega ◽  
Ido Sirota ◽  
Patrick Vetere

2021 ◽  
Vol 32 ◽  
Author(s):  
Emanuele Perrone ◽  
Ilaria Capasso ◽  
Tina Pasciuto ◽  
Alessandro Gioè ◽  
Salvatore Gueli Alletti ◽  
...  

2014 ◽  
Vol 24 (3) ◽  
pp. 600-607 ◽  
Author(s):  
Farr Reza Nezhat ◽  
Tamara Natasha Finger ◽  
Patrick Vetere ◽  
Amir Reza Radjabi ◽  
Mario Vega ◽  
...  

ObjectiveThe objective of this study was to examine perioperative outcomes, including complication rates, of conventional laparoscopy (CL) versus robotic-assisted laparoscopy (RALS) in the evaluation and management of early, advanced, and recurrent ovarian, fallopian tube, and peritoneal cancer.MethodsThis is a retrospective analysis of a prospectively maintained database of surgery performed from July 2008 to December 2012. Sixty-three women had 83 surgeries performed; 22 surgeries for early-stage disease (International Federation of Gynecology and Obstetrics stage I) and 61 for advanced and/or recurrent disease.ResultsOf the 22 for early stage, 10 were CL, 9 were RALS, and 3 were laparoscopy converted to laparotomy (LP). There was no significant difference between CL and RALS in estimated blood loss (EBL,P= 0.27) or length of stay (LOS,P= 0.43); however, both had significantly less EBL (P= 0.03 and 0.03, respectively) and LOS (P= 0.03 and 0.03) than LP. There was no difference in OR time among the groups (P= 0.79). One patient (33%) had an intraoperative complication in LP. One patient (10%) had a postoperative complication in CL, 2 (22%) in RALS, and 1 (33%) in LP, with no significant difference (P= 0.61).Among the 42 patients with advanced/recurrent disease, 61 surgeries were performed: 14 diagnostic procedures and 47 cytoreductive surgeries. Of the 47, there was no difference in operating room time (P= 0.10). There was no difference in EBL or LOS between CL and RALS (P= 0.82,P= 0.87); however, both were less in CL (P< 0.001 andP= 0.02) and RALS (P= 0.01 andP= 0.02) compared with LP. There were 5 (63%) intraoperative transfusions in LP and none in CL or RALS. When including all surgeries for advanced/recurrent disease, there was 1 intraoperative complication (12%) in LP. There was no difference in postoperative complications between groups (P= 0.89); 8 patients (19%) had postoperative complications in CL, 2 (18%) in RALS, and 2 (25%) in LP. Overall, there were no grade 4 or 5 complications and no perioperative or intraoperative deaths.ConclusionsIn our experience, perioperative outcomes are comparable between CL and RALS in both early and advanced/recurrent disease and not inferior to laparotomy, making CL and RALS an acceptable approach in selected patients.


Sign in / Sign up

Export Citation Format

Share Document